Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Return on Sales of 0.36% for Q1 2026, up 27.0% year-over-year from 0.28% in Q1 2025, and up 140.12% quarter-over-quarter from 0.89% in Q4 2025.
Sol-Gel Technologies (SLGL) Return on Sales (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Return on Sales for 9 consecutive years, with 0.36% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 27.0% year-over-year to 0.36%; the TTM figure through Mar 2026 stood at 0.03% (up 1.0% YoY), while the FY2025 annual figure was 0.03%, up 2.0% from the prior year.
- Return on Sales rose to 0.36% in Q1 2026 per SLGL's latest filing, from 0.89% in the prior quarter.
- Across five years, Return on Sales topped out at 0.36% in Q1 2026 and bottomed at 5.09% in Q4 2022.
- Historically, Return on Sales has averaged 0.63% across 5 years, with a median of 0.11% in 2023.
- Annual changes were most pronounced in 2022 — Return on Sales sank 510 bps — and 2023, when it soared 390 bps.
- Sol-Gel Technologies' Return on Sales stood at 5.09% in 2022, then soared by 77 bps to 1.19% in 2023, then slumped by 69 bps to 2.01% in 2024, then soared by 56 bps to 0.89% in 2025, then surged by 140 bps to 0.36% in 2026.
- Business Quant data shows SLGL's Return on Sales at 0.36% in Q1 2026, 0.89% in Q4 2025, and 0.16% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36% |
| Dec 31, 2025 | -0.89% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.09% |
| Dec 31, 2024 | -2.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | -1.19% |
| Sep 30, 2023 | -0.30% |
| Jun 30, 2023 | -0.11% |
| Dec 31, 2022 | -5.09% |
| Sep 30, 2022 | -0.14% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.09% |
| Mar 31, 2021 | 0.06% |
| Dec 31, 2020 | -0.03% |